Oded Kraft, Co-Founder & CEO of GrayMatters Health
We are living in a mental health epidemic. An estimated 26 percent of Americans ages 18 and older – about one in four adults – suffer from…
Continue Reading
Digital biomarkers – data collected by wearable digital medical devices – can be used to inform the development of new drugs and medical devices and to evaluate their effectiveness. Listen as Jordan Brayanov and…
Continue Reading
Spinal Cord Stimulation (SCS) is a well-established therapy for treating chronic pain. However, perceived treatment response to SCS therapy may vary among people with chronic pain due to diverse needs and backgrounds. Patient Reported…
Continue Reading
The University of Edinburgh has joined the NEURii collaboration, which will explore the use of data and digital solutions to complement treatment options for people living with dementia. NEURii hopes to solve issues that…
Continue Reading
Hackensack Meridian Health has partnered with Canary Health, an AI-driven speech analysis start-up, to develop vocal biomarker technology for screening anxiety and cognitive diseases. Canary Speech’s proprietary machine learning models assess digital biomarkers in…
Continue Reading
Health system Hackensack Meridian Health is partnering with Canary Health, which uses proprietary machine learning modeling to assess digital biomarkers in the human voice to explain or predict health-related outcomes. This will enable Hackensack…
Continue Reading
As the healthcare industry strives toward precision medicine, it will be essential for care providers to gain an intimate view of a patient’s response to treatment to determine its impact on their quality of…
Continue Reading
